Skip to main content
. 2024 Nov 19;16(22):3870. doi: 10.3390/cancers16223870

Table 2.

Consensus molecular subtypes of colorectal cancer.

Subtype Prevalence Features
CMS1 (Microsatellite instability immune) 14% Hypermutated
Microsatellite unstable
Strong immune activation
CMS2 (Canonical) 37% Epithelial
WNT and MYC signaling activation
CMS3 (Metabolic) 13% Epithelial
Metabolic dysregulation
CMS4 (Mesenchymal) 23% TGF-β activation
Stromal invasion
Angiogenesis